Koert Ritmeijer

Summary

Publications

  1. doi Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence
    Koert Ritmeijer
    Public Health Department, Medecins Sans Frontieres, Amsterdam, The Netherlands
    Clin Infect Dis 53:e152-8. 2011
  2. ncbi Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 74:76-80. 2006
  3. ncbi A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Clin Infect Dis 43:357-64. 2006
  4. ncbi Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan
    Zahir O E Babiker
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 76:689-93. 2007
  5. doi Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome
    Rachel Ter Horst
    Medecins Sans Frontieres, Amsterdam, The Netherlands
    Clin Infect Dis 46:1702-9. 2008
  6. ncbi Unresponsiveness to AmBisome in some Sudanese patients with kala-azar
    Marius Mueller
    Medecins Sans Frontieres, Plantage Middenlaan 14, 1018 DD Amsterdam, The Netherlands
    Trans R Soc Trop Med Hyg 101:19-24. 2007
  7. pmc Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends
    Stanislaw Gorski
    Medecins Sans Frontieres, Amsterdam, The Netherlands
    PLoS Negl Trop Dis 4:e705. 2010
  8. ncbi Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy
    Yosef Melaku
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 77:89-94. 2007
  9. ncbi Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Trop Med Int Health 12:404-14. 2007
  10. ncbi Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan
    Hans Veeken
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Trop Med Int Health 8:164-7. 2003

Collaborators

Detail Information

Publications16

  1. doi Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence
    Koert Ritmeijer
    Public Health Department, Medecins Sans Frontieres, Amsterdam, The Netherlands
    Clin Infect Dis 53:e152-8. 2011
    ....
  2. ncbi Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 74:76-80. 2006
    ..Further diagnostic work-up of dipstick-negative patients with clinically suspected VL is important. The ease and convenience of the dipstick test will allow decentralization and improved access to care in disease-endemic areas in Sudan...
  3. ncbi A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Clin Infect Dis 43:357-64. 2006
    ..Oral miltefosine has been proven to be safe and effective in the treatment of Indian VL but has not been studied in Africa or in persons with HIV and VL coinfection...
  4. ncbi Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan
    Zahir O E Babiker
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 76:689-93. 2007
    ..Lymph node and splenic aspirations were similarly accurate as tests of cure after treatment of 50 VL patients in southern Sudan. Pre-treatment LNA results were negative in 20 cases of severe post kala-azar dermal leishmaniasis...
  5. doi Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome
    Rachel Ter Horst
    Medecins Sans Frontieres, Amsterdam, The Netherlands
    Clin Infect Dis 46:1702-9. 2008
    ..Coinfection with human immunodeficiency virus (HIV) and Leishmania donovani visceral leishmaniasis (VL) in Africa is an emerging, poorly understood disease...
  6. ncbi Unresponsiveness to AmBisome in some Sudanese patients with kala-azar
    Marius Mueller
    Medecins Sans Frontieres, Plantage Middenlaan 14, 1018 DD Amsterdam, The Netherlands
    Trans R Soc Trop Med Hyg 101:19-24. 2007
    ..002) and underlying immunosuppressive disease: tuberculosis (three cases) or HIV (two cases). Because AmBisome monotherapy may fail in Sudan, a combination of AmBisome and SSG is recommended for relapse cases...
  7. pmc Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends
    Stanislaw Gorski
    Medecins Sans Frontieres, Amsterdam, The Netherlands
    PLoS Negl Trop Dis 4:e705. 2010
    ..Risk factors associated with L. donovani visceral leishmaniasis (VL; kala azar) relapse are poorly characterized...
  8. ncbi Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy
    Yosef Melaku
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Am J Trop Med Hyg 77:89-94. 2007
    ..22, 95% CI = 0.10-0.50) in 2003, and 86% lower (OR = 0.14, 95% CI = 0.07-0.27) in 2004-2005. In remote field settings, 17 days of SSG combined with PM gives better survival and initial cure rates than 30 days of SSG monotherapy...
  9. ncbi Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan
    Koert Ritmeijer
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Trop Med Int Health 12:404-14. 2007
    ..The effectiveness of ITN depends on behavioural factors, which differ between communities...
  10. ncbi Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan
    Hans Veeken
    Medecins Sans Frontieres Holland, Amsterdam, The Netherlands
    Trop Med Int Health 8:164-7. 2003
    ..The rK39 dipstick is a good screening test for kala-azar; but further development is required before it can replace the DAT as a diagnostic test in endemic areas of the Sudan...
  11. pmc Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study
    Erika van den Bogaart
    Department of Biomedical Research, Parasitology Unit, Royal Tropical Institute KIT, Amsterdam, The Netherlands
    BMC Public Health 13:332. 2013
    ..In VL-endemic areas with unstable and seasonal malaria, vulnerability to the disease persists through all age-groups, suggesting that in these populations, malaria may easily co-occur with VL, with potentially severe clinical effects...
  12. ncbi A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan
    Marius Mueller
    Medecins Sans Frontieres, 67 74 Saffron Hill, London EC1N 8QX, UK
    J Antimicrob Chemother 58:811-5. 2006
    ..We present a series of pregnant women with VL treated with either sodium stibogluconate or liposomal amphotericin B (AmBisome), or both, in eastern Sudan over 16 months...
  13. ncbi Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan
    Simon Collin
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Clin Infect Dis 38:612-9. 2004
    ..7), and splenomegaly (OR, 2.9). A higher risk of death was associated with episodes of diarrhea (OR, 1.4), vomiting (OR, 2.7), and bleeding (OR, 2.9). Relapse and PKDL occurred in 3.9% and 10.0% of cases, respectively...
  14. ncbi Unseen Kala-azar deaths in south Sudan (1999-2002)
    Simon M Collin
    Department of Infectious and Tropical Diseases, Infectious Disease Unit, London School of Hygiene and Tropical Medicine, London, UK
    Trop Med Int Health 11:509-12. 2006
    ..To estimate the number of deaths due to primary or relapse kala-azar (KA), which occurred unseen within the catchment area of Médecins Sans Frontières (MSF) clinics in southern Sudan...
  15. pmc Treating HIV/AIDS and leishmaniasis coinfection in Ethiopia
    Aranka Anema
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC
    CMAJ 172:1434-5. 2005
  16. ncbi Liposomal amphotericin B for the treatment of visceral leishmaniasis
    Caryn Bern
    Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 43:917-24. 2006
    ..The public health community should work to broaden access to preferential liposomal amphotericin B pricing by public sector VL treatment programs...